Delivery Order SPE2DB20D2014-SPE2DB24FA96B

Award Date 1/31/24
Potential Completion Date 2/1/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award ceiling value is $1,084.38 and the contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. The contract has an ultimate completion date of December 6, 2024 and was awarded on December 5,...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a ceiling value of $2,125.11 and is a firm-fixed-price, delivery order with a completion date of May 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical,...
The federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,559.44 and an ultimate completion date of December 4, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements, indicating...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on April 18, 2024. The contract has a ceiling value of $7,685.70 and is a firm fixed-price delivery order with an ultimate completion date of April 19, 2024. There is no set-aside designation for this...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract, valued at $25,619.00, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company that has been awarded multiple federal contracts to supply a wide range of medical products and medications to government agencies, including the DoD and Department of Veterans Affairs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of M-M-R II vaccine vials. The contract is a Delivery Order with a Firm Fixed Price of $2,745.38 and a completion date of May 8, 2024. Amerisourcebergen, through its Corporate Office Division, has a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $15,154.88. The contract is a firm fixed-price delivery order with a performance period ending on January 31, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $43,492.00 and is a firm fixed-price Delivery Order that runs through April 21, 2023. The contract was awarded on April 20, 2023 and does not have a set-aside designation,...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company, on May 23, 2024. The contract has a ceiling value of $11,887.64 and is a firm fixed-price delivery order. It does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite...
This federal contract award is for the delivery of M-M-R II VACCINE VIALS to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,763.46 and is a Firm Fixed Price Delivery Order with a period of performance through January 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FA96B
    Delivery Order

This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, for a ceiling value of $1,248.84. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is February 1, 2024.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. The contract does not have a set-aside designation.

Generated 9/20/24, 9:23 AM